Current scenario of the Male Health diseases treatment landscape
Market Heats Up as Managing Benign Prostatic Hyperplasia Through Devices Gains Traction
ewing-sarcoma-key-companies-and-emerging-therapies
Ewing Sarcoma: Key Companies and Emer...

Bone tumors are uncommon in adults, however, are a frequent cause of neoplastic diseases among children and...

obesity-causes-diagnosis-risk-factors-epidemiology-therapies-pipeline-treatment-therapeutics-market
The Obesity Pandemic: What can we do ...

Obesity today is a global crisis; the number of cases is on a continuous rise. As per the WHO,  “durin...

global-burden-of-sexually-transmitted-diseases-std
A Globally Rising Burden of Sexually ...

Caused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden...

Prostate Cancer Market
Prostate Cancer Market Experiences an Influx of the Pharma Players Veering the Market Ahead

Prostate Cancer Market Size is Expected to Increase with a CAGR of 8.1% in the 7MM for the study period of 2017-30 owing to rich Pipeline, Increasing Awareness and Better Treatment Options.A m...


pharma-news
Moderna’s COVID-19 Vaccine; Quidel’s Lyra gets EUA from FDA; Neurotrope and Metuchen ...

Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273.  The results of interim Phase I clinical trial showed promising outcomes in term...


Novartis signs; Sosei passes; Amgen remunerates; J&J remunerates for RSV drug

Novartis signs USD 2.1Billion for Endocyte acquisition Novartis has inked USD 2.1 billion agreement to takeover Endocyte. Endocyte, a biopharmaceutical company, headquartered in Indiana, licensed t...


transthyretin amyloidosis
CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff

Rice University researchers tested CRISPR to cure sickle cell, now preparing for upcoming challenges A team of Researchers led by Rice University has recently tested CRISPR to correct the sickle ce...


Remicade’s launch; Endo cuts jobs; Analysts downgrade Pfizer; Corning $500M glass project

Samsung and Merck launch Remicade biosim at 35% discount After the first biosimilar of Johnson & Johnson’s big-selling immunology drug Remicade hit the market last year at a modest discount, an...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...